<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1'); </script>
Logo-bi
Bioimpacts. 2025;15: 30984 | Published on: 2025 Oct 29. doi: 10.34172/bi.30984
PMID: 41322389        PMCID: PMC12663752

Review

The role of artificial intelligence in enhancing breast cancer screening and diagnosis: A review of current advances

Faezeh Firuzpour 1,2 ORCID, MohammadAli Heydari 3, Cena Aram 4 * ORCID, Ali Alishvandi 5 ORCID

Cited by CrossRef: 0

1- Alishvandi A, Aram C, Barancheshemeh M, Shekari T, Firuzpour F, Yazdi M. In silico design of a multi-epitope vaccine against NSCLC targeting T-cell exhaustion and metastasis: insights from RNA-seq and molecular dynamics simulation analysis. Netw Model Anal Health Inform Bioinforma. 2026;15(1) [Crossref]
2- Taki A, Shareef A, Arora V, Oweis R, Jyothi S, Singh U, Sahoo S, Chauhan A, Alimova F, Sameer H, Yaseen A, Athab Z, Adil M. Ferroptosis in cancer: integrating multi-omics, AI-driven biomarkers, and translational challenges. Clinica Chimica Acta. 2026;591:121131 [Crossref]
3- Xu Y, Shen H, Shang D, Zhu C. Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer. Front Oncol. 2026;15 [Crossref]
4- Venugopal J, Panneerselvam S, Patan A, Theivendren P. Artificial Intelligence in Personalized Breast Cancer Drug Safety: From Preclinical Toxicology to Clinical Risk Management. Clinical Therapeutics. 2026;48(5):449 [Crossref]
5- Ghezel M, Aram C, Alishvandi A, Barancheshmeh M, Firuzpour F, Khodabandehloo M, Mohammadian S, Rahimi M, Keikha M. Harnessing innate lymphoid cells (ILCs) for cancer immunotherapy: A new frontier in precision immuno-oncology. Translational Research. 2026;290:61 [Crossref]
6- Abuhassan Q, Saleh K, Jyothi S, Sahoo R, Prakash P, Mukherjee G, Sinha A, Boyqulov T. Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies. Bioimpacts. 2026;16:33219 [Crossref]
7- Huang N, Guan Y. Pre-treatment endocrine–nutritional signatures predict clinical benefit from PD-1/PD-L1 blockade in hematologic malignancies. Front Nutr. 2026;12 [Crossref]
8- Xin Z, Zhu X, Qu H, Ai X, Wang K, Li X, Wang M, Li P, Han Z, Qu N, Yu W, Chen H. Pretreatment cardiometabolic risk in newly diagnosed breast cancer: a molecular subtype analysis. Front Cardiovasc Med. 2026;13 [Crossref]

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 19% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons